Biblio

38 resultats trouvés
Filtres: Auteur is Gyan, Emmanuel  [Clear All Filters]
P
Nicolini FE, Vantard N, Giraudier S, Heiblig M, Johnson-Ansah H, Roy L, Bulabois C-E, Caillot D, Escoffre-Barbe M, Jourdan E et al..  2014.  Prospective Analysis of the Quality of Life of Chronic Phase CML Patients on Second Generation Tyrosine Kinase Inhibitors after Imatinib Failure. an Observational Study. BLOOD. 124
Nicolini FE, Vantard N, Giraudier S, Heiblig M, Johnson-Ansah H, Roy L, Bulabois C-E, Caillot D, Escoffre-Barbe M, Jourdan E et al..  2014.  Prospective Analysis of the Quality of Life of Chronic Phase CML Patients on Second Generation Tyrosine Kinase Inhibitors after Imatinib Failure. an Observational Study. BLOOD. 124
R
Houillier C, Taillandier L, Dureau S, Lamy T, Laadhari M, Chinot O, Molucon-Chabrot C, Soubeyran P, Gressin R, Choquet S et al..  2019.  Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study. JOURNAL OF CLINICAL ONCOLOGY. 37:823+.
Lamy T, Damaj G, Soubeyran P, Gyan E, Cartron G, Bouabdallah K, Gressin R, Cornillon J, Banos A, Le Du K et al..  2018.  R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma. BLOOD. 131:174-181.
Tout M, Casasnovas O, Meignan M, Lamy T, Morschhauser F, Salles G, Gyan E, Haioun C, Mercier M, Feugier P et al..  2017.  Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report. BLOOD. 129:2616-2623.
Le Gouill S, Thieblemont C, Oberic L, Moreau A, Bouabdallah K, Gyan E, Damaj G, Ribrag V, Feugier P, Casasnovas O et al..  2016.  Rituximab Maintenance after Autologous Stem Cell Transplantation Prolongs Survival in Younger Patients with Mantle Cell Lymphoma: Final Results of the Randomized Phase 3 LyMa Trial of the Lysa/Goelams Group. BLOOD. 128
Le Gouill S, Thieblemont C, Oberic L, Bouabdallah K, Gyan E, Damaj G, Ribrag V, Bologna S, Gressin R, Casasnovas O et al..  2014.  Rituximab Maintenance Versus Wait and Watch after Four Courses of R-DHAP Followed By Autologous Stem Cell transplantation in Previously Untreated Young Patients with Mantle Cell Lymphoma: First Interim Analysis of the Phase III Prospective Lyma Trial, a L. BLOOD. 124
T
Le Gouill S, Bouabdallah K, Cartron G, Gressin R, Lamy T, Coiffier B, Thieblemont C, Haioun C, Casasnovas O, Gyan E et al..  2014.  T-3:A Multicenter Phase IB Dose Escalation Study to Evaluate the Safety, Feasibility and Efficacy of the Temsirolimus (Torisel (TM))-CHOP-Rituximab (T-R-CHOP), Temsirolimus (Torisel (TM))-FC-Rituximab (T-R-FC) and Temsirolimus (Torisel (TM))-DHA-Rituximab. BLOOD. 124
Le Gouill S, Bouabdallah K, Cartron G, Gressin R, Lamy T, Coiffier B, Thieblemont C, Haioun C, Casasnovas O, Gyan E et al..  2014.  T-3:A Multicenter Phase IB Dose Escalation Study to Evaluate the Safety, Feasibility and Efficacy of the Temsirolimus (Torisel (TM))-CHOP-Rituximab (T-R-CHOP), Temsirolimus (Torisel (TM))-FC-Rituximab (T-R-FC) and Temsirolimus (Torisel (TM))-DHA-Rituximab. BLOOD. 124
Le Gouill S, Bouabdallah K, Burroni B, Lamy T, Gressin R, Cartron G, Thieblemont C, Sarkozy C, Haioun C, Casasnovas O et al..  2016.  Temsirolimus in Combination with Three Different Immuno-Chemotherapy Regimens in Relapse and Refractory Mantle Cell Lymphoma, Final Results of the T-3 Phase IB Trial of the Lysa Group. BLOOD. 128
Soussain C, Houillier C, Ghesquieres H, Soubeyran P, Chinot O, Taillandier L, Houot R, Ahle G, Gyan E, Chabrot C et al..  2016.  The French LOC Network for Primary CNS Lymphoma (PCNSL) Patients: What Can We Learn from a Large National Database? BLOOD. 128
Bensalem A, Cartron G, Specks U, Mulleman D, Gyan E, Cornec D, Desvignes C, Casasnovas O, Lamy T, Lepretre S et al..  2022.  The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition. CLINICAL PHARMACOKINETICS. 61:423-437.
W
Houillier C, Taillandier L, Lamy T, Chinot O, Molucon-Chabrot C, Soubeyran P, Gressin R, Choquet S, Damaj G, Thyss A et al..  2016.  Whole Brain Radiotherapy (WBRT) Versus Intensive Chemotherapy with Haematopoietic Stem Cell Rescue (IC plus HCR) for Primary Central Nervous System Lymphoma (PCNSL) in Young Patients: An Intergroup Anocef-Goelams Randomized Phase II Trial (PRECIS). BLOOD. 128

Pages